8-K: Health In Tech Reports Strong 2025 Growth, Positive 2026 Outlook

Health In Tech announced robust full-year 2025 financial results, including significant revenue and Adjusted EBITDA growth, alongside an optimistic revenue outlook for 2026.

Summary

• Full year 2025 revenues reached $33.3 million, marking a 71% increase year-over-year (YoY).
• Full year 2025 Adjusted EBITDA was $4.1 million, an 81% increase YoY.
• Full year 2025 net income stood at $1.3 million, up 91% YoY.
• Fourth quarter (Q4) 2025 revenues were $7.5 million, representing a 53% increase YoY.
• Q4 2025 Adjusted EBITDA was $0.3 million, a decrease from $0.5 million in Q4 2024.
• Q4 2025 net loss was $0.3 million, compared to a $0.1 million net loss in Q4 2024.
• The number of billed enrolled employees (EEs) grew 23% YoY to 22,515 as of December 31, 2025.
• The distribution network of Brokers, Third-party Administrators (TPAs), and Agencies expanded 34% YoY to 858 partners as of December 31, 2025.
• Cash balance as of December 31, 2025, was $7.7 million, a slight decrease from $7.8 million at December 31, 2024.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong report, highlighting significant growth in key financial metrics and an optimistic outlook for 2026, despite some Q4 declines in profitability. The strategic initiatives and management appointments further bolster confidence in future performance.

Positives

• Full year 2025 revenues increased 71% year-over-year to $33.3 million.
• Full year 2025 Adjusted EBITDA grew 81% year-over-year to $4.1 million.
• Full year 2025 net income rose 91% year-over-year to $1.3 million.
• Billed enrolled employees increased 23% year-over-year to 22,515.
• Distribution network expanded 34% year-over-year to 858 partners.
• Q4 revenues increased 53% year-over-year to $7.5 million.
• The company expects full-year 2026 revenue to be in the range of $45 million to $50 million, representing 35% to 50% year-over-year growth.
• Health In Tech's AI-driven platform enables new capabilities to be developed and deployed within approximately one to two quarters, providing a meaningful competitive advantage over the traditional insurance industry's one to two-year implementation cycles.
• Engaged Amazon Web Services (AWS) Advanced Tier Services Partner Ciklum to accelerate development of its AI-Driven InsurTech platform.
• Appointed Sri Rajagopalan as Chief Technology Officer and Zain Hasan as Chief Growth Officer to strengthen leadership in technology and revenue acceleration.
• Introduced over 100 pre-configured stop-loss self-funded healthcare plans for employers, streamlining the renewal process and reducing cycle times.
• Hosted the inaugural independent hitDavos InsurTech Summit, driving brand visibility and global leadership engagement.

Negatives

• Q4 2025 Adjusted EBITDA decreased to $0.3 million compared to $0.5 million in Q4 2024.
• Q4 2025 net loss widened to $0.3 million compared to a $0.1 million net loss in Q4 2024.
• Cash balance decreased from $7.8 million at December 31, 2024, to $7.7 million at December 31, 2025.
• Accounts receivable, net, decreased from $1,647,103 in 2024 to $756,288 in 2025.
• Research and development expenses decreased significantly in Q4 2025 ($213,113) and full year 2025 ($1,569,262) compared to 2024, which could indicate a shift in R&D strategy or externalization of development efforts.

Risks

• Actual results may differ materially from forward-looking statements due to known and unknown risks, uncertainties, and other factors.
• Forward-looking statements involve factors beyond Health In Tech's control which could, and likely will, affect actual results, levels of activity, performance, or achievements.
• Specific risks and uncertainties are detailed in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the U.S. Securities and Exchange Commission.

Future Outlook

Health In Tech anticipates full-year 2026 revenue to be between $45 million and $50 million, representing 35% to 50% year-over-year growth. This outlook is based on continued strong demand for the company's AI-enabled underwriting marketplace and successful deployment of new features. The company expects continued growth driven by expanding engagement across its distribution network and the full deployment of new features launched in January 2026. In the first half of 2026, Health In Tech plans to complete market testing of its Three-Year Rate stabilization program and initiate beta testing of a new data-driven solution, reflecting a strategy to layer incremental, high-value services onto its scalable platform.

Management Comments

• "2025 was a defining year of disciplined execution and measurable platform scale for Health In Tech."
• "We strengthened our AI-enabled underwriting marketplace, expanded carrier, broker, and TPA integrations, and further automated core insurance workflows to drive efficiency and margin scalability."
• "We extended underwriting capabilities into larger employer segments and continued enhancing our technology architecture to support enterprise-level throughput across the approximately $300 billion U.S. claims administration market."
• "Most importantly, we translated operational progress into financial performance, delivering 71% year-over-year revenue growth."
• "As we enter 2026, our focus is on advancing a fully integrated marketplace model that expands beyond underwriting to include additional services such as claims administration and administrative cost-containment solutions."
• "This structured program architecture enables agencies to align standardized offerings with target employer segments, empowering brokers to deliver execution-ready solutions with greater speed, consistency, and operational efficiency."
• "The result is shorter sales cycles, improved conversion visibility, and scalable distribution leverage, while maintaining the flexibility to customize for employer-specific needs."
• "Together, these initiatives reflect our strategy of layering incremental, high-value services onto an already commercialized and scalable platform to drive durable growth and increasing operating leverage."

Industry Context

StockSavvy.ai notes that Health In Tech operates in the rapidly evolving InsurTech sector, leveraging AI to disrupt the traditional health insurance industry, particularly within the self-funded health insurance segment. The company's ability to deploy new capabilities within one to two quarters, significantly faster than the one to two years typical for traditional insurers, provides a strong competitive advantage. This agility allows it to quickly respond to market demands and scale its technology platform more efficiently, positioning it favorably against legacy market participants in the approximately $300 billion U.S. claims administration market. The strategic hires and AWS partnership further underscore its commitment to technological leadership and market expansion.

Comparison to Industry Standards

• Health In Tech's accelerated development cycle of 1-2 quarters for new product and service implementations significantly outperforms the traditional insurance industry's typical 1-2 year timeframe, demonstrating a clear competitive advantage in speed to market and adaptability.
• The expansion of its distribution network to 858 partners and 22,515 billed enrolled employees indicates strong market penetration and adoption within the self-funded health insurance segment, a key growth area for InsurTech platforms, suggesting it is gaining traction against established players.

Management Changes

Stakeholder Impact

• Shareholders: Potential positive impact due to strong revenue and Adjusted EBITDA growth, optimistic 2026 outlook, and strategic initiatives aimed at sustained growth and operating leverage.
• Employees: Potential positive impact from company growth and expansion, possibly leading to increased opportunities and stability.
• Customers (Employers): Positive impact from new offerings like 100+ pre-configured stop-loss plans, the Three-Year Rate stabilization program, and data-driven insights, leading to cost stability, predictability, and efficiency in self-funded health plans.
• Brokers/TPAs/Agencies: Positive impact from an expanded distribution network, streamlined processes, and execution-ready solutions, leading to shorter sales cycles, improved conversion visibility, and scalable distribution leverage.
• Carriers/Service Providers: Continued integration and expansion within Health In Tech's marketplace, potentially increasing their reach and efficiency.

Next Steps

• Complete market testing of the Three-Year Rate stabilization program in the first half of 2026.
• Initiate beta testing of a new data-driven solution integrating physiological and claims data in the first half of 2026.
• Continue expanding engagement across the distribution network.
• Ensure full deployment of new features launched in January 2026.
• Advance a fully integrated marketplace model to include additional services such as claims administration and administrative cost-containment solutions.

Key Dates

Recommendation

The company demonstrated strong full-year 2025 financial performance with significant revenue and Adjusted EBITDA growth, indicating successful execution of its AI-enabled InsurTech strategy. The 2026 revenue guidance projects continued robust growth (35-50% YoY), supported by strategic hires, accelerated platform development, and new product launches designed to enhance competitive advantage and market penetration. While Q4 profitability saw a slight dip, the overall trajectory and strategic initiatives suggest strong future potential in a growing market segment, making it an attractive investment.

Keywords

InsurTech, AI, health insurance, self-funded plans, financial results, Q4 2025, full year 2025, revenue growth, Adjusted EBITDA, underwriting, claims administration, stop-loss, Nasdaq, HIT